Biotech company Alnylam Pharmaceuticals Inc filed new lawsuits on Friday against Pfizer Inc and Moderna Inc in Delaware federal court, again claiming that the companies' Covid-19 vaccines infringe its patents.
Alnylam is again seeking an unspecified share of royalties from the companies' vaccine sales. Pfizer earned US$37.8 billion from sales of its Covid-19 vaccine Comirnaty last year, while Moderna made $18.4 billion from its vaccine Spikevax. Cambridge, Massachusetts-based Alnylam first sued Moderna and Pfizer last March. It filed another pair of complaints last July over an additional LNP patent, which were later consolidated with its earlier lawsuits.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: